Format

Send to

Choose Destination
Immunol Res. 2014 Aug;59(1-3):236-42. doi: 10.1007/s12026-014-8532-1.

Prostate cancer vaccines in combination with additional treatment modalities.

Author information

1
Department of Urology, University of Iowa, 375 Newton Road, Iowa City, IA, 52242, USA.

Abstract

Immunotherapy has been investigated in both preclinical studies and clinical trials as a new therapy for prostate cancer. Vaccines, including those that utilize dendritic cells, viruses, or DNA, immunize against prostate-specific antigen and prostatic acid phosphatase. The vaccines have long been studied as monotherapy for the cancer, but increasingly more trials have been initiated in combination with other modalities. These include radiation, chemotherapy, and androgen deprivation therapy. This review describes and discusses the various combinations of vaccine immunotherapies.

PMID:
24838261
DOI:
10.1007/s12026-014-8532-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center